NCT05087563View on ClinicalTrials.gov

Neurolens Convergence Insufficiency Study

NATerminatedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

November 22, 2021

Primary Completion Date

May 31, 2022

Study Completion Date

May 31, 2022

Conditions
Binocular Vision DisorderConvergence InsufficiencyComputer Vision Syndrome
Interventions
DEVICE

Neurolens spectacle lens

spectacle lens

DEVICE

Placebo spectacle lens

spectacle lens for refractive correction

Trial Locations (9)

33155

Suarez Optical, Miami

40241

Gaddie Eye Centers, Louisville

51246

Rock River Eye Care, Rock Rapids

76092

Eyes and Ears, Southlake

76308

Clarke EyeCare Center, Wichita Falls

80526

Fort Collins Family Eye Care, Fort Collins

92821

Brea Optometry, Brea

97239

South Waterfront Eye Care, Portland

06040

Total Vision Eyecare, Manchester

Sponsors

Lead Sponsor

Neurolens Inc.
All Listed Sponsors
lead

Neurolens Inc.

INDUSTRY

NCT05087563 - Neurolens Convergence Insufficiency Study | Biotech Hunter | Biotech Hunter